Hepatitis Monthly
Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
1. Angiogenesis Is Associated With Aggressive Biology That Counterbalances With Tumor Immunogenicity in Hepatocellular Carcinoma
- Vaghjiani R. , et al.
2. Current Advances in Hepatocellular Carcinoma: Transition from: Traditional to Advanced Technology
- Gautam S. , et al.
3. Clinical effect analysis of different regimens of capecitabine in the treatment of patients with advanced colon cancer
- Ju F. , et al.
4. Efficacy and Safety of Metronomic Capecitabine in Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
- Gupta N. , et al.
5. BCL11B expression in hepatocellular carcinoma relates to chemosensitivity and clinical prognosis
- Abe H. , et al.
8. RMI2 is a prognostic biomarker and promotes tumor growth in hepatocellular carcinoma
- Li Y. , et al.
9. An Overview of the Synthetic Route to the Marketed Formulations of Pyrimidine: A Review
- Kumar A. , et al.
10. Case Report: Durable Response to Very Low Dose Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma
- Tang T.Y. , et al.
11. Capecitabine Treatment: A Safe and Effective Therapy in the Field of Oncology
- Beenet L. , et al.
12. CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma
- Li B. , et al.
13. Systemic therapies in elderly patients with advanced hepatocellular carcinoma: Do not forget metronomic capecitabine
- Wilhelmi M. , et al.
14. Systemic therapies in elderly patients with advanced hepatocellular carcinoma: do not forget metronomic capecitabine
- Kapacee Z.A. , et al.
15. Ramucirumab and other new systemic therapies for hepatocellular carcinoma: Still uncovered the problem of Child-Pugh B patients
- Wilhelmi M. , et al.
16. Novel ferrocene derivatives induce G0/G1 cell cycle arrest and apoptosis through the mitochondrial pathway in human hepatocellular carcinoma
- Zheng J. , et al.
17. Gene Polymorphism of MUC15, MMP14, BRAF, and COL1A1 Is Associated with Capsule Formation in Hepatocellular Carcinoma
- Sun W. , et al.
18. Global analysis of gene expression signature and diagnostic/prognostic biomarker identification of hepatocellular carcinoma
- Wang J. , et al.
19. The Effect of Ferroptosis-Related Genes on Prognosis and Tumor Mutational Burden in Hepatocellular Carcinoma
- Zhang H. , et al.
20. A New CYP2E1 Inhibitor, 12-Imidazolyl-1-dodecanol, Represents a Potential Treatment for Hepatocellular Carcinoma
- Diesinger T. , et al.
21. Upregulation of Nei-Like DNA Glycosylase 3 Predicts Poor Prognosis in Hepatocellular Carcinoma
- Wu D. , et al.
22. Curative effect of endostar combined with oxaliplatin in the treatment of primary hepatic carcinoma and its influence on immune cells
- Lei C. , et al.
23. Immunotherapy in hepatocellular carcinoma
- Buonaguro L. , et al.
24. Potentiating cancer vaccine efficacy in liver cancer
- Tagliamonte M. , et al.